Bora CDMO Bora CDMO

X

Find the latest news about Sanifit aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Sanifit
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
3655 Nobel Drive Suite #540 San Diego, CA 92122
Telephone
Telephone
34 971 439 925

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://endpts.com/joan-perello-set-out-17-years-ago-to-develop-a-drug-and-today-hes-being-rewarded-with-a-424m-biotech-buyout/

John Carroll ENDPTS
23 Nov 2021

https://www.evaluate.com/vantage/articles/news/snippets/vifor-plumps-double-acquisition

Elizabeth Cairns EVALUATE
23 Nov 2021

http://www.globenewswire.com/fr/news-release/2021/02/10/2173031/0/en/Sanifit-Granted-Orphan-Drug-Designation-by-the-FDA-for-SNF472-for-the-Treatment-of-Peripheral-Arterial-Disease-in-Patients-with-End-stage-Kidney-Disease.html

GLOBENEWSWIRE
10 Feb 2021

https://www.pharmiweb.com/press-release/2020-10-23/sanifit-presents-new-data-for-snf472-in-treatment-of-vascular-calcification-at-asn-kidney-week-2020

PHARMIWEB
23 Oct 2020

https://www.globenewswire.com/news-release/2020/07/20/2064233/0/en/Sanifit-to-start-new-clinical-development-program-of-SNF472-in-End-Stage-Kidney-Disease-patients-with-Peripheral-Artery-Disease.html

GLOBENEWSWIRE
20 Jul 2020

https://www.lundbeckfonden.com/snf472-mechanism-of-action-data-published-in-british-journal-of-pharmacology/

LUNDBECKFONDEN
25 Jun 2020

https://www.globenewswire.com/news-release/2020/02/13/1984420/0/en/First-patient-dosed-in-pivotal-phase-3-trial-of-SNF472-in-calciphylaxis.html

GLOBENEWSWIRE
13 Feb 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY